New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 11, 2025 - Roche announced the FDA approval of Evrysdi (risdiplam) 5 mg tablet, for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
Download PDF
Return to publications
